User profiles for Gunalp Uzun
Günalp Uzun, MDCenter for Clinical Transfusion Medicine Verified email at med.uni-tuebingen.de Cited by 3073 |
Hyperbaric oxygen therapy as an anti-infective agent
Hyperbaric oxygen therapy (HBOT) involves inhalation of 100% oxygen at supra-atmospheric
ambient pressure. HBOT is used as either a primary or adjunctive treatment in the …
ambient pressure. HBOT is used as either a primary or adjunctive treatment in the …
[HTML][HTML] Primary immune thrombocytopenia: novel insights into pathophysiology and disease management
Immune thrombocytopenia (ITP) is an autoimmune disorder defined by a significantly reduced
number of platelets in blood circulation. Due to low levels of platelets, ITP is associated …
number of platelets in blood circulation. Due to low levels of platelets, ITP is associated …
[HTML][HTML] Platelet-neutrophil interaction in COVID-19 and vaccine-induced thrombotic thrombocytopenia
Coronavirus disease 2019 (COVID-19) is known to commonly induce a thrombotic diathesis,
particularly in severely affected individuals. So far, this COVID-19-associated coagulopathy …
particularly in severely affected individuals. So far, this COVID-19-associated coagulopathy …
How reliable are cultures of specimens from superficial swabs compared with those of deep tissue in patients with diabetic foot ulcers?
M Mutluoglu, G Uzun, V Turhan, L Gorenek… - Journal of Diabetes and …, 2012 - Elsevier
PURPOSE: To assess the reliability of cultures of superficial swabs (SS) by comparing them
with cultures of concomitantly obtained deep tissue (DT) specimens in patients with diabetic …
with cultures of concomitantly obtained deep tissue (DT) specimens in patients with diabetic …
The implications of the presence of osteomyelitis on outcomes of infected diabetic foot wounds
…, AK Sivrioglu, M Eroglu, G Uzun… - … journal of infectious …, 2013 - Taylor & Francis
Aim: To assess the effect of the presence of osteomyelitis in patients with a diabetic foot
infection. Methods: We reviewed the records of diabetic patients hospitalized at our medical …
infection. Methods: We reviewed the records of diabetic patients hospitalized at our medical …
Procalcitonin as a diagnostic aid in diabetic foot infections
G Uzun, E Solmazgul, H Curuksulu… - The Tohoku journal of …, 2007 - jstage.jst.go.jp
Exp. Med., 2007, 213 (4), 305-312── The diagnosis of diabetic foot infection (DFI) is usually
a challenge to the clinician. Procalcitonin (PCT), a 116-amino acid propeptide of calcitonin…
a challenge to the clinician. Procalcitonin (PCT), a 116-amino acid propeptide of calcitonin…
Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia
…, Y Kucukardali, F Tangi, A Erikci, G Uzun… - Journal of Diabetes and …, 2012 - Elsevier
AIM: The aim was to evaluate the therapeutic effectiveness of granulocyte colony-stimulating
factor (G-CSF) mobilized peripheral blood mononuclear cells (PBMNCs) in critical limb …
factor (G-CSF) mobilized peripheral blood mononuclear cells (PBMNCs) in critical limb …
Increasing incidence of Gram-negative organisms in bacterial agents isolated from diabetic foot ulcers
Introduction: In the present study, we sought to identify the bacterial organisms associated
with diabetic foot infections (DFIs) and their antibiotic sensitivity profiles. Methodology: We …
with diabetic foot infections (DFIs) and their antibiotic sensitivity profiles. Methodology: We …
Causative pathogens and antibiotic resistance in diabetic foot infections: a prospective multi-center study
M Hatipoglu, M Mutluoglu, V Turhan, G Uzun… - Journal of Diabetes and …, 2016 - Elsevier
Aim Clinical practice guidelines for the management of diabetic foot infections developed by
the Infectious Diseases Society of America (IDSA) are commonly used worldwide. The issue …
the Infectious Diseases Society of America (IDSA) are commonly used worldwide. The issue …
[HTML][HTML] Treatment of drug-induced immune thrombocytopenias
I Marini, G Uzun, K Jamal, T Bakchoul - Haematologica, 2022 - ncbi.nlm.nih.gov
Several therapeutic agents can cause thrombocytopenia by either immune-mediated or non-immune-mediated
mechanisms. Non-immune-mediated thrombocytopenia is due to direct …
mechanisms. Non-immune-mediated thrombocytopenia is due to direct …